Neurology Congress Presents Unique Learning Opportunity for Fellows and Residents

In less than 2 weeks, dozens of neurologists from some of the country’s top institutions will convene in New York City for the 1^st Annual International Congress on the Future of Neurology.

The meeting, which will take place September 27-28, 2019, at the InterContinental New York Times Square, will feature 2 days of education intended to better inform neurology professionals of the latest research and clinical trends impacting practice today.

Led by Congress Chair Stephen D. Silberstein, MD, Director of the Jefferson Headache Center and professor of neurology at Thomas Jefferson University Hospital in Philadelphia, the agenda features presentations from leaders in the field, including Richard Lipton, MD, Fred Lublin, MD, Elizabeth Thiele, MD, PhD, Michael Thorpy, MD, Richard Isaacson, MD, and more, covering topics across the breadth of neurology.

“Many neurologists have become super specialized and may not be aware of what new developments are happening in the other sub-specialties in neurology,” said Silberstein. “It is our goal to bring together the best in our field to discuss the current trends and medical innovations that benefit our patients and we hope that all who attend will walk away with a better understanding of the developments and trends in neurology.”

The Congress, which is fully accredited for up to 14 AMA PRA Category 1 credits, also presents a unique opportunity for Fellows and residents specializing in neurology to network with leaders in the field and also share their work. Attendees are invited to submit poster abstracts for presentation via the Congress website.

“Trainees can learn about the latest and the most relevant issues within different subspecialties of neurology in a concise yet thorough manner. This meeting will help the trainees stay up to date by presentations and discussions from the experts in the field, as well as provide a forum for them to share their own work,” said Jee Bang, MD, MPH, Clinical Director of the Johns Hopkins Huntington Disease Center of Excellence and Co-Director of the Movement Disorders Fellowship Program at Johns Hopkins Medicine. Bang will present on the therapeutic potential of antisense oligonucleotides and immunotherapy in Huntington disease in a session titled “Treatment Frontiers in Movement Disorders” on Saturday, September 28^th.

Given the Congress’ focus on providing attendees with the most up to date information, the meeting is also a great opportunity for trainees to assess their knowledge of sub-specialties ahead of evaluations.  

“The 1^st Annual International Congress on the Future of Neurology promises to be a high-yield meeting that should be of particular interest to neurology resident and fellow trainees. The breadth of sub-specialty topics and the expertise of session moderators and faculty promises to provide trainees access to the latest in neurologic therapies which can help them both in their clinical practice but also in their preparation for board certification examinations,” said Jeffrey Ratliff, MD, clinical assistant professor of neurology at the Jefferson Comprehensive Parkinson’s Disease and Movement Disorders Center. “Where many board preparation materials may not have up to date content on new therapies across neurology, the focus of this conference is to bring all neurologists up to speed on the cutting edge of available neurologic therapies for the patients we see every day.”

Ratliff, who is also Associate Director of the Neurology Residency Program and Director of the Movement Disorders Fellowship at Jefferson Health, will moderate the movement disorders session and present on the topic of the potential of vesicular monoamine transporter 2 (VMAT2) inhibitors for tardive dyskinesia.

Specialists whose areas of expertise cross over other disciplines, including sleep and stroke experts, also have a unique opportunity to network with and learn from their peers in neurology, allowing them to apply the latest clinical pearls to their practice.

“Sleep medicine is a discipline which is heavily influenced by the neurosciences. This conference provides an excellent opportunity to learn about the neurophysiologic, anatomic, and behavioral underpinnings of sleep, and the many disorders that affect sleep and wakefulness, from leading experts in the field,” said Karl Doghramji, MD, Medical Director of the Jefferson Sleep Disorders Center and Program Director of the Fellowship in Sleep Medicine at Thomas Jefferson University Hospital, where he is also professor of neurology, psychiatry, and medicine.

Doghramji, who will moderate the session on sleep disorders, will also present on the topic of excessive daytime sleepiness and obstructive sleep apnea.

Don’t miss out on this unique opportunity. Register today and receive 25% off registration fees with code Neuro19SI.

This content originally appeared on NeurologyLive. Stay tuned for an exciting announcement.